S&P Futures
4,373.50 +12.50 (+0.29%) Dow Futures
34,315.00 +83.00 (+0.24%) Nasdaq Futures
14,923.00 +53.50 (+0.36%) Russell 2000 Futures
1,799.20 +6.50 (+0.36%) Crude Oil
90.41 +0.38 (+0.42%) Gold
1,940.70 -4.90 (-0.25%)
After hours:
Chart Events
Performance Outlook
| Previous Close | 20.08 |
| Open | 20.35 |
| Bid | 0.00 x 2900 |
| Ask | 0.00 x 2200 |
| Day's Range | 19.79 - 20.36 |
| 52 Week Range | 19.79 - 40.12 |
| Volume | |
| Avg. Volume | 2,135,450 |
| Market Cap | 3.873B |
| Beta (5Y Monthly) | 1.02 |
| PE Ratio (TTM) | 36.16 |
| EPS (TTM) | 0.55 |
| Earnings Date | Nov 17, 2023 - Nov 21, 2023 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 26.60 |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for DOCS
Related Research
- Doximity, Inc.DOCS: Lowering target price to $21.00DOXIMITY INC-CLASS A has an Investment Rating of HOLD; a target price of $21.000000; an Industry Subrating of Medium; a Management Subrating of Low; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of High.RatingFair ValueEconomic Moat5 days agoArgus Research
Motley Fool3 Top Stocks That Just Went on Sale
Worse yet, Enphase Energy (NASDAQ: ENPH), The Toro Company (NYSE: TTC), and Doximity (NYSE: DOCS) are down between 29% and 53% on the year. Posting a jaw-dropping total return north of 2,700% over the last five years -- even after its drop in 2023 -- Enphase and its semiconductor-based microinverters and batteries have been thriving amid the solar industry's boom. Converting energy at the individual solar module level, Enphase's microinverters are superior to solar systems using a string inverter system, which cannot account for partial shading of a solar panel layout as effectively.
ZacksImplied Volatility Surging for Doximity (DOCS) Stock Options
Investors need to pay close attention to Doximity (DOCS) stock based on the movements in the options market lately.
Motley FoolThis Is the Biggest Problem With Doximity's Stock
Doximity (NYSE: DOCS) operates a networking platform for doctors that claims to have 80% of U.S. physicians on it. It's an impressive statistic, but that hasn't been enough of a reason for investors continue buying up the stock this year. While other growth stocks have been thriving due to artificial intelligence (AI), there's not the same level of excitement around Doximity -- even though the company has launched its own chatbot, DocsGPT.
